<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03339284</url>
  </required_header>
  <id_info>
    <org_study_id>R17103M</org_study_id>
    <secondary_id>2017-002254-37</secondary_id>
    <nct_id>NCT03339284</nct_id>
  </id_info>
  <brief_title>QLB and Laparoscopic Nephrectomy, Postoperative Pain and Recovery</brief_title>
  <official_title>Quadratus Lumborum Block (QLB) With and Without Dexamethasone: the Effect on Postoperative Pain and Recovery After Laparoscopic Nephrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tampere University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tampere University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are ca 900 new cases of kidney cancer in Finland/year. The curative therapy for kidney
      cancer is partial or total nephrectomy depending on the localization and the size of tumor.
      Main of these operations are laparoscopic.

      Epidural analgesia is considered as most effective for the treatment of postoperative pain
      after open nephrectomy, but after laparoscopic operation parenteral and enteral opioids
      combined with paracetamol (acetaminophen) usually offer adequate postoperative pain relief.
      However, the need for opioids postoperatively may be high and side effects, such as sedation
      and nausea, are common. On the other hand epidural analgesia has some contraindications and
      risks for serious complications. Nevertheless, inadequately treated acute postoperative pain
      is considered as one of the main risk factors for persistent postoperative pain.

      Recently quadratus lumborum block (QLB) has gained popularity in the treatment of
      postoperative pain after various surgeries in the area from hip to mamilla. It is more
      beneficial than other peripheral blocks, since it covers also the visceral nerves. A single
      shot QLB has reported to last up to 48 hours.

      Perineural dexamethasone added to local anesthetic has been reported to prolong the duration
      of analgesia of the perineural nerve block, but it's effect on the duration of QLB is not
      known.

      90 kidney cancer patients with planned laparoscopic nephrectomy aging 18-85 will be recruited
      based on a power calculation. The primary outcome measure is the postoperative cumulative
      opioid consumption. Secondary outcomes are acute pain (NRS scale), nausea, vomiting,
      mobilisation and long term outcomes such as quality of life and persistent pain.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Patients are randomized and allocated in blocks of nine to either placebo or QLB with dexamethasone or QLB without dexamethasone group</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>opiate consumption</measure>
    <time_frame>24 hours</time_frame>
    <description>cumulative opiate consumption postoperatively</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>opiate consumption</measure>
    <time_frame>72 hours</time_frame>
    <description>cumulative opiate consumption postoperatively</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative nausea</measure>
    <time_frame>72 hours</time_frame>
    <description>numerical rating scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain score</measure>
    <time_frame>7 days</time_frame>
    <description>numerical rating scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mobilization</measure>
    <time_frame>72 hours</time_frame>
    <description>time to standing up and mobilizing after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>quality of life</measure>
    <time_frame>12 months</time_frame>
    <description>SF36 query</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>persistent pain</measure>
    <time_frame>12 months</time_frame>
    <description>paindetect McGill</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>functional query</measure>
    <time_frame>12 months</time_frame>
    <description>assessment how pain in operation region limits daily functions</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>postoperative vomiting</measure>
    <time_frame>72 hours</time_frame>
    <description>amount of vomites</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Postoperative Pain</condition>
  <condition>Chronic Pain Post-Proceduraal</condition>
  <condition>Nausea and Vomiting, Postoperative</condition>
  <arm_group>
    <arm_group_label>QLB with dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single sided US-guided QLB using ropivacaine 3,75 mg/ml 20 ml and dexamethasone 5 mg/ml 0,4 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>QLB without dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Single sided US-guided QLB using ropivacaine 3,75 mg/ml 20 ml and isotonic natriumchloride solution (NaCl 0,9%) 0,4 ml</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Single sided US-guided QLB using isotonic natriumchloride solution (NaCl 0,9%) 20,4 ml</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone sodium phosphate</intervention_name>
    <description>Dexamethasone injection</description>
    <arm_group_label>QLB with dexamethasone</arm_group_label>
    <other_name>Oradexon</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine Hydrocloride</intervention_name>
    <description>Ropivacaine injection</description>
    <arm_group_label>QLB with dexamethasone</arm_group_label>
    <arm_group_label>QLB without dexamethasone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sodium Chloride 9mg/mL</intervention_name>
    <description>Sodium Chloride injection</description>
    <arm_group_label>QLB without dexamethasone</arm_group_label>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with renal cancer coming to the laparoscopic radical nephrectomy

        Exclusion Criteria:

          -  age under 18y or over 85y

          -  diabetes type 1 with complications

          -  no co-operation or inadequate finnish language skills

          -  persistent pain for other reason

          -  severe hepatic insufficiency or paracetamol (acetaminophen) is contraindicated for
             other reason

          -  any type of steroid in regular use

          -  oxycodone contraindicated

          -  medications changing notably paracetamol (acetaminophen) and/or ropivacaine metabolism
             in regular use
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Maija Kalliomaki, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Tampere University Hospital, Department of Anesthesia</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eija Junttila, PhD</last_name>
    <phone>+358331166001</phone>
    <email>eija.junttila@pshp.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrus Korgvee, MD</last_name>
    <phone>+358331169617</phone>
    <email>andrus.korgvee@pshp.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tampere University Hospital</name>
      <address>
        <city>Tampere</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrus Korgvee, MD</last_name>
      <phone>0358331169617</phone>
      <email>andrus.korgvee@pshp.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <reference>
    <citation>Finnish Cancer Registry. Cancer in Finland 2007-2011. Cancer Society of Finland Publication, Helsinki.</citation>
  </reference>
  <reference>
    <citation>Ljungberg B1, Bensalah K2, Canfield S3, Dabestani S4, Hofmann F5, Hora M6, Kuczyk MA7, Lam T8, Marconi L9, Merseburger AS7, Mulders P10, Powles T11, Staehler M12, Volpe A13, Bex A14. EAU guidelines on renal cell carcinoma: 2014 update.Eur Urol. 2015 May;67(5):91324.doi:10.1016/j.eururo.2015.01.005. Epub 2015 Jan 21</citation>
  </reference>
  <reference>
    <citation>Chan DY, Cadeddu JA, Jarrett TW, Marshall FF, Kavoussi LR. Laparoscopic radical nephrectomy: cancer control for renal cell carcinoma. J Urol. 2001 Dec;166(6):2095-9; discussion 2099-100.</citation>
    <PMID>11696714</PMID>
  </reference>
  <reference>
    <citation>Mathuram Thiyagarajan U, Bagul A, Nicholson ML. Pain management in laparoscopic donor nephrectomy: a review. Pain Res Treat. 2012;2012:201852. doi: 10.1155/2012/201852. Epub 2012 Oct 23.</citation>
    <PMID>23150820</PMID>
  </reference>
  <reference>
    <citation>Rawal N. Current issues in postoperative pain management. Eur J Anaesthesiol. 2016 Mar;33(3):160-71. doi: 10.1097/EJA.0000000000000366. Review.</citation>
    <PMID>26509324</PMID>
  </reference>
  <reference>
    <citation>Murouchi T, Iwasaki S, Yamakage M. Quadratus Lumborum Block: Analgesic Effects and Chronological Ropivacaine Concentrations After Laparoscopic Surgery. Reg Anesth Pain Med. 2016 Mar-Apr;41(2):146-50. doi: 10.1097/AAP.0000000000000349.</citation>
    <PMID>26735154</PMID>
  </reference>
  <reference>
    <citation>Blanco R, Ansari T, Riad W, Shetty N. Quadratus Lumborum Block Versus Transversus Abdominis Plane Block for Postoperative Pain After Cesarean Delivery: A Randomized Controlled Trial. Reg Anesth Pain Med. 2016 Nov/Dec;41(6):757-762. Erratum in: Reg Anesth Pain Med. 2018;43:111.</citation>
    <PMID>27755488</PMID>
  </reference>
  <reference>
    <citation>Chakraborty A, Goswami J, Patro V. Ultrasound-guided continuous quadratus lumborum block for postoperative analgesia in a pediatric patient. A A Case Rep. 2015 Feb 1;4(3):34-6. doi: 10.1213/XAA.0000000000000090.</citation>
    <PMID>25642956</PMID>
  </reference>
  <reference>
    <citation>Kirksey MA, Haskins SC, Cheng J, Liu SS. Local Anesthetic Peripheral Nerve Block Adjuvants for Prolongation of Analgesia: A Systematic Qualitative Review. PLoS One. 2015 Sep 10;10(9):e0137312. doi: 10.1371/journal.pone.0137312. eCollection 2015.</citation>
    <PMID>26355598</PMID>
  </reference>
  <reference>
    <citation>Huynh TM, Marret E, Bonnet F. Combination of dexamethasone and local anaesthetic solution in peripheral nerve blocks: A meta-analysis of randomised controlled trials. Eur J Anaesthesiol. 2015 Nov;32(11):751-8. doi: 10.1097/EJA.0000000000000248. Review.</citation>
    <PMID>25774458</PMID>
  </reference>
  <reference>
    <citation>Albrecht E, Kern C, Kirkham KR. A systematic review and meta-analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia. 2015 Jan;70(1):71-83. doi: 10.1111/anae.12823. Epub 2014 Aug 14. Review.</citation>
    <PMID>25123271</PMID>
  </reference>
  <reference>
    <citation>Kehlet H, Jensen TS, Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006 May 13;367(9522):1618-25. Review.</citation>
    <PMID>16698416</PMID>
  </reference>
  <reference>
    <citation>Gordon DB, de Leon-Casasola OA, Wu CL, Sluka KA, Brennan TJ, Chou R. Research Gaps in Practice Guidelines for Acute Postoperative Pain Management in Adults: Findings From a Review of the Evidence for an American Pain Society Clinical Practice Guideline. J Pain. 2016 Feb;17(2):158-66. doi: 10.1016/j.jpain.2015.10.023. Epub 2015 Dec 21. Review.</citation>
    <PMID>26719073</PMID>
  </reference>
  <reference>
    <citation>Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, Carter T, Cassidy CL, Chittenden EH, Degenhardt E, Griffith S, Manworren R, McCarberg B, Montgomery R, Murphy J, Perkal MF, Suresh S, Sluka K, Strassels S, Thirlby R, Viscusi E, Walco GA, Warner L, Weisman SJ, Wu CL. Management of Postoperative Pain: A Clinical Practice Guideline From the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016 Feb;17(2):131-57. doi: 10.1016/j.jpain.2015.12.008. Erratum in: J Pain. 2016 Apr;17(4):508-10. Dosage error in article text.</citation>
    <PMID>26827847</PMID>
  </reference>
  <reference>
    <citation>Gustavsson A, Bjorkman J, Ljungcrantz C, Rhodin A, Rivano-Fischer M, Sjolund KF, Mannheimer C. Socio-economic burden of patients with a diagnosis related to chronic pain--register data of 840,000 Swedish patients. Eur J Pain. 2012 Feb;16(2):289-99. doi: 10.1016/j.ejpain.2011.07.006.</citation>
    <PMID>22323381</PMID>
  </reference>
  <reference>
    <citation>Blanco R, Ansari T, Girgis E. Quadratus lumborum block for postoperative pain after caesarean section: A randomised controlled trial. Eur J Anaesthesiol. 2015 Nov;32(11):812-8. doi: 10.1097/EJA.0000000000000299.</citation>
    <PMID>26225500</PMID>
  </reference>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 3, 2017</study_first_submitted>
  <study_first_submitted_qc>November 9, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">November 13, 2017</study_first_posted>
  <last_update_submitted>December 27, 2017</last_update_submitted>
  <last_update_submitted_qc>December 27, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 28, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
    <mesh_term>Chronic Pain</mesh_term>
    <mesh_term>Vomiting</mesh_term>
    <mesh_term>Postoperative Nausea and Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone 21-phosphate</mesh_term>
    <mesh_term>Ropivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

